Tatva Chintan Pharma Chem Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
TATVA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Tatva Chintan Pharma Chem has submitted a compliance certificate to the stock exchanges as required under Regulation 74(5) of the SEBI Depositories Regulations, 2018. The certificate was issued by MUFG Intime India Private Limited, the company's Registrar and Share Transfer Agent, for the quarter ended 31 December 2025. It confirms that all share certificates received for dematerialisation during the quarter were properly verified, processed, and the depositories were updated as the registered owners within the prescribed timelines. The filing is a routine regulatory submission with no financial or business disclosure.
This is a routine procedural filing with no material impact on the company's financials, operations, or stock price. It is a standard quarterly compliance requirement applicable to all listed companies and carries no new information for investors.